Pathstone Holdings’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.59M Buy
27,584
+1,584
+6% +$329K 0.02% 548
2026
Q1
$5.49M Buy
26,000
+3,968
+18% +$855K 0.02% 537
2025
Q4
$4.53M Sell
22,032
-607
-3% -$114K 0.02% 605
2025
Q3
$3.55M Buy
22,639
+19
+0.1% +$2.94K 0.01% 702
2025
Q2
$3.8M Buy
22,620
+1,091
+5% +$162K 0.02% 658
2025
Q1
$2.97M Buy
21,529
+1,035
+5% +$132K 0.01% 772
2024
Q4
$2.42M Sell
20,494
-556
-3% -$64.9K 0.01% 868
2024
Q3
$2.33M Sell
21,050
-295
-1% -$30.8K 0.01% 892
2024
Q2
$2.1M Sell
21,345
-305
-1% -$31.1K 0.01% 904
2024
Q1
$2.42M Sell
21,650
-997
-4% -$108K 0.01% 826
2023
Q4
$2.28M Buy
+22,647
New +$2.25M 0.01% 688

Other funds holding CAH

Pathstone Holdings's CAH Position: Q2 2026 in Review

Pathstone Holdings increased its Cardinal Health (CAH) stake by 6.1% in Q2 2026, buying an estimated $329K and bringing the position to 27,584 shares worth $6.59M. The position accounts for 0.02% of the portfolio, ranked #548.

Pathstone Holdings first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Pathstone Holdings held 27,584 shares of Cardinal Health worth $6.59M as of Q2 2026.
  • Pathstone Holdings bought 1,584 Cardinal Health shares in Q2 2026, an estimated $329K.
  • Cardinal Health made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #548 holding.
  • Pathstone Holdings first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.